Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
607 JPY | 0,00% |
|
+3,94% | -48,21% |
26/06 | JCR Pharmaceuticals corrigeert gedeeltelijk de geconsolideerde resultaten voor het boekjaar 2024 | MT |
31/05 | JCR Pharmaceuticals' winst over het hele jaar met 46% gestegen | MT |
ETF's gepositioneerd op JCR Pharmaceuticals Co., Ltd.
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
1.67% | 19 M€ | +4,31% | - | |
0.30% | 14 M€ | +14,19% | ||
0.07% | 57 M€ | +22,50% | ||
0.04% | 69 M€ | +19,54% | ||
0.03% | 17 M€ | +18,02% | - | |
0.02% | 4 931 M€ | +21,00% | ||
0.02% | 9 764 M€ | +20,38% | ||
0.02% | 19 753 M€ | +18,95% | - | |
0.02% | 138 841 M€ | +19,96% | ||
0.01% | 775 M€ | -.--% | - | |
0.01% | 7 M€ | +3,51% | - | |
0.00% | 10 M€ | -3,35% | - | |
0.00% | 35 M€ | +4,82% | - | |
0.00% | 36 M€ | +10,49% | - | |
0.00% | 414 M€ | +12,00% | - | |
0.00% | 40 M€ | +7,33% | - | |
0.00% | 324 M€ | +8,15% | - | |
0.00% | 32 M€ | +4,52% | - |
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-48,21% | 471 mln. | |
+55,32% | 819 mld. | |
-6,75% | 351 mld. | |
+13,56% | 329 mld. | |
+10,68% | 298 mld. | |
+16,57% | 242 mld. | |
+2,04% | 225 mld. | |
+13,31% | 217 mld. | |
+8,48% | 168 mld. | |
-2,81% | 158 mld. |
- Beurs
- Aandelen
- Koers 4552
- ETF's JCR Pharmaceuticals Co., Ltd.